IRCT20191231045969N1招募中3 期
Effect of intravenous somatostatin on prevention of pancreatitis after ERCP (Endoscopic Retrograde Cholangio-Pancreatography) in comparison with control group
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age over 18 years
- •Ability to sign consent
- •Intact papillae
- •No contraindication for somatostatin and diclofenac
- •Having an ERCP indication
排除标准
- •Sphincterotomy
- •Acute pancreatitis
- •Basic amylase above 200
- •Allergy to somatostatin and diclofenac
研究者
相似试验
已完成
4 期
Role of somatostatin in the incidence of post – ERCP pancreatitisIRCT20080921001264N11Gorgan University of Medical Sciences360
已完成
不适用
Efficacy and safety of preoperative somatostatine analogue treatment in acromegalyAcromegalyJPRN-UMIN000015518Hokkaido University50
进行中（未招募）
1 期
Effect of long-acting somatostatin on disease progression in nephropathy due to autosomal dominant polycystic disease a long-term three year follow-up study - ALADIAutosomal Dominant Polycystic Kidney Disease ADPKDMedDRA version: 6.1 Level: SOC Classification code 10038359EUCTR2005-005552-41-ITIST. DI RICERCHE FARMACOLOG. M. NEGRI66
进行中（未招募）
1 期
Research on the effectiveness of octreotide in Gastric Antral Vascular Ectasia (GAVE)in patients with anemia.Gastric Antral Vascular Ectasia (also known as watermelon stomach)EUCTR2020-004075-41-NLRadboudumc12
招募中
不适用
Effectiveness of Somatostatin Analogues in patients with Gastric Antral Vascular Ectasia and symptomatic gastrointestinal bleeding: SAGAVE Pilot studyNL-OMON21472Radboudumc12